These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 4572151

  • 21. Absence of graft-versus-host disease in the isolated vascularized bone marrow transplant.
    Tai CY, Strande LF, Eydelman R, Sheng X, VanTran JL, Matthews MS, Hewitt CW.
    Transplantation; 2004 Jan 27; 77(2):316-9. PubMed ID: 14743002
    [Abstract] [Full Text] [Related]

  • 22. Immunological considerations of bone marrow transplantation.
    Uphoff DE.
    Transplant Proc; 1969 Mar 27; 1(1):39-43. PubMed ID: 4944248
    [No Abstract] [Full Text] [Related]

  • 23. Quantitative analysis of the chimaeric state in mice. II. Cytological examination of the proportion of proliferating donor and host cells in runt disease in mice.
    Nakić B, Kastelan A, Mikuska J, Bunarević A.
    Immunology; 1967 Jun 27; 12(6):615-27. PubMed ID: 6027421
    [Abstract] [Full Text] [Related]

  • 24. Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats.
    Aksu AE, Horibe E, Sacks J, Ikeguchi R, Breitinger J, Scozio M, Unadkat J, Feili-Hariri M.
    Clin Immunol; 2008 Jun 27; 127(3):348-58. PubMed ID: 18387852
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L, Lubin I, Factorowich I, Lapidot Z, Reich S, Reisner Y, Slavin S.
    J Immunol; 1994 Sep 15; 153(6):2562-7. PubMed ID: 8077666
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
    Iwai T, Tomita Y, Zhang QW, Shimizu I, Nomoto K, Yasui H.
    Transpl Int; 2005 May 15; 17(12):795-803. PubMed ID: 15856178
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Longevity of AKR mice increased by reduced incidence of thymic lymphomas. A preliminary report.
    Uphoff DE.
    Transplantation; 1969 Aug 15; 8(2):203-4. PubMed ID: 4896334
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effect of tritiated thymidine and 5-bromodeoxyuridine on development of immunologically competent lymphocytes.
    McGregor DD.
    Immunology; 1969 Jan 15; 16(1):83-90. PubMed ID: 4890409
    [Abstract] [Full Text] [Related]

  • 33. [Prevention of the graft vs host reaction in rats by means of allogeneic antilymphocyte serum following bone marrow transplantation].
    Jeannet M, Vaucher A, Gervasoni C.
    Schweiz Med Wochenschr; 1972 Nov 04; 102(44):1598-600. PubMed ID: 4405059
    [No Abstract] [Full Text] [Related]

  • 34. Effect of posttransplant cyclosporine treatment on the development of syngeneic GVHD in recipients of UV-B irradiated bone marrow cells.
    Ohajekwe OA, Hardy MA, Oluwole SF.
    Transplant Proc; 1995 Feb 04; 27(1):1385. PubMed ID: 7878922
    [No Abstract] [Full Text] [Related]

  • 35. Prolongation of kidney graft survival by cyclophosphamide-induced tolerance in rats.
    Eto M, Nishimura Y, Matsuo K, Omoto K, Goto K, Kumuzawa J, Nomoto K.
    J Urol; 1995 May 04; 153(5):1693-6. PubMed ID: 7715012
    [Abstract] [Full Text] [Related]

  • 36. TRANSPLANTATION IMMUNITY OF GESTATIONAL ORIGIN IN INFANT RATS.
    BILLINGHAM RE, PALM J, SILVERS WK.
    Science; 1965 Jan 29; 147(3657):514-6. PubMed ID: 14237209
    [Abstract] [Full Text] [Related]

  • 37. Some comments on lymphocyte-mediated cytotoxicity and blocking serum activity in allograft tolerance.
    Hellström I, Hellström KE.
    Johns Hopkins Med J Suppl; 1974 Jan 29; 3():301-5. PubMed ID: 4607384
    [No Abstract] [Full Text] [Related]

  • 38. Suppressor mechanisms active in the control of graft-v-host disease.
    Tutschka PJ.
    Transplant Proc; 1987 Dec 29; 19(6 Suppl 7):69-74. PubMed ID: 2962355
    [No Abstract] [Full Text] [Related]

  • 39. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B, Uharek L, Gaska T, Gassmann W, Löffler H, Müller-Ruchholtz W.
    Bone Marrow Transplant; 1993 Dec 29; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [Abstract] [Full Text] [Related]

  • 40. [Experimental research on homografts, Tolerance and runt disease in Fischer rats].
    Visentini P, Mazzoleni F, Paladini E.
    Acta Chir Ital; 1966 Dec 29; 22(4):369-72. PubMed ID: 4868150
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.